Læknablaðið - 01.06.2022, Blaðsíða 29

L ÆKNABL AÐIÐ 2022/108 297
R A N N S Ó K N
Greinin barst til blaðsins 9. febrúar 2022, samþykkt til birtingar 3. maí 2022.
Heimildir
1. Arciniegas DB. Psychosis. Continuum (Minneap Minn) 2015; 21: 715-36.
2. Pagsberg AK. Schizophrenia spectrum and other psychotic disorders. Eur Child Adolesc
Psychiatry 2013; 22 Suppl 1: S3-9.
3. Saha S, Chant D, Welham J, et al. A systematic review of the prevalence of schizophrenia.
PLoS Med 2005; 2: e141.
4. Cheng SC, Schepp KG. Early Intervention in Schizophrenia: A Literature Review. Arch
Psychiatr Nurs 2016; 30: 774-81.
5. Millan MJ, Fone K, Steckler T, et al. Negative symptoms of schizophrenia: clinical charact-
eristics, pathophysiological substrates, experimental models and prospects for improved
treatment. Eur Neuropsychopharmacol 2014; 24: 645-92.
6. Jin H, Mosweu I. The Societal Cost of Schizophrenia: A Systematic Review.
Pharmacoeconomics 2017; 35: 25-42.
7. Mueser KT, McGurk SR. Schizophrenia. Lancet 2004; 363: 2063-72.
8. Evensen S, Wisløff T, Lystad JU, et al. Prevalence, Employment Rate, and Cost of
Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using
Comprehensive Health and Welfare Registers. Schizophr Bull 2016; 42: 476-83.
9. Miyamoto S, Miyake N, Jarskog LF, et al. Pharmacological treatment of schizophrenia: a
critical review of the pharmacology and clinical effects of current and future therapeutic
agents. Mol Psychiatr 2012; 17: 1206-27.
10. Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychot-
ic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373: 31-41.
11. Meltzer HY. Update on typical and atypical antipsychotic drugs. Annu Rev Med 2013:; 64:
393-406.
12. Ingimarsson O, MacCabe JH, Haraldsson M, et al. Risk of diabetes and dyslipidemia
during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.
Nord J Psychiatry 2017; 71: 496-502.
13. Correll CU, Galling B, Pawar A, et al. Comparison of Early Intervention Services vs
Treatment as Usual for Early-Phase Psychosis A Systematic Review, Meta-analysis, and
Meta-regression. Jama Psychiatry 2018; 75: 555-65.
14. Penttilä M, Jääskeläinen E, Hirvonen N, et al. Duration of untreated psychosis as predictor
of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J
Psychiatry 2014; 205: 88-94.
15. Upplýsingarit - Laugarásinn meðferðargeðdeild. Landspítali, Reykjavík 2021.
16. Koletsi M, Niersman A, van Busschbach JT, et al. Working with mental health problems:
clients' experiences of IPS, vocational rehabilitation and employment. Soc Psychiatry
Psychiatr Epidemiol 2009; 44: 961-70.
17. Santesteban-Echarri O, Paino M, Rice S, et al. Predictors of functional recovery in first-epis-
ode psychosis: A systematic review and meta-analysis of longitudinal studies. Clin
Psychol Rev 2017; 58: 59-75.
18. Tsang HW, Leung AY, Chung RC, et al. Review on vocational predictors: a systematic revi-
ew of predictors of vocational outcomes among individuals with schizophrenia: an update
since 1998. Aust N Z J Psychiatry 2010; 44: 495-504.
19. Aldrei fleiri brautskráðir doktorar. Hagstofan 2020. hagstofa.is/utgafur/frettasafn/
menntun/utskrifadir-nemendur-ur-framhaldsskolum-og-haskolum-2018-2019/ - apríl 2021.
20. Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu
Rev Clin Psychol 2014; 10: 425-48.
21. Sveinsson O, Thorleifsson K, Aspelund T, et al. Rannsókn á áhættuþáttum hjarta- og æða-
sjúkdóma hjá geðklofasjúklingum á geðsviði Landspítala. Læknablaðið 2012; 98: 399-402.
22. Turner MA, Boden JM, Smith-Hamel C, et al. Outcomes for 236 patients from a 2-year
early intervention in psychosis service. Acta Psychiatr Scand 2009; 120: 129-37.
23. Archie S, Rush BR, Akhtar-Danesh N, et al. Substance use and abuse in first-episode
psychosis: prevalence before and after early intervention. Schizophr Bull 2007; 33: 1354-63.
24. Strålin P, Hetta J. First episode psychosis and comorbid ADHD, autism and intellectual
disability. Eur Psychiatry 2019; 55: 18-22.
25. Saemundsen E, Magnússon P, Georgsdóttir I, et al. Prevalence of autism spectrum dis-
orders in an Icelandic birth cohort. BMJ Open 2013; 3.
26. Vinnulag við greiningu og meðferð athyglisbrests með ofvirkni (ADHD). Embætti land-
læknis 2012.
27. Eiríksdóttir VH, Magnússon A. Þróun á notkun lyfja við athyglisbrest og ofvirkni.
Talnabrunnur - Fréttabréf landlæknis um heilbrigðisupplýsingar 2020; 14.
28. Karatekin C, White T, Bingham C. Shared and nonshared symptoms in youth-onset
psychosis and ADHD. J Atten Disord 2010; 14: 121-31.
29. KPMG. Þróun örorku. Stjórnarráðið, Reykjavík 2018.
30. Endurhæfingarlífeyrir. Tryggingarstofnun 2021. tr.is/endurhaefing/endurhaefingarlifeyrir
- apríl 2021.
31. Thorup A, Petersen L, Jeppesen P, et al. The quality of life among first-episode psychotic
patients in the OPUS trial. Schizophr Res 2010; 116: 27-34.
32. Secher RG, Hjorthøj CR, Austin SF, et al. Ten-year follow-up of the OPUS specialized early
intervention trial for patients with a first episode of psychosis. Schizophr Bull 2015; 41:
617-26.
33. Atvinnuþátttaka er meiri og atvinnuleysi minna meðal þeirra sem hafa meiri menntun.
Hagstofan 2015. hagstofa.is/utgafur/frettasafn/menntun/mannfjoldi-eftir-menntunar-
stodu-2014/ - apríl 2021.
34. Henkel D. Unemployment and substance use: a review of the literature (1990-2010). Curr
Drug Abuse Rev 2011; 4: 4-27.
35. Jónsson AJ, Birgisdóttir H, Sigurðsson E. Eykur notkun kannabis hættu á geðrofi og þróun
geðklofa? Læknablaðið 2014; 100: 443-51.
E N G L I S H S U M M A R Y
Ragna Kristín Guðbrandsdóttir1
Oddur Ingimarsson1,2
1University of Iceland, Faculty of Medicine 2Mental
Health Services, Landspítali University Hospital of
Iceland.
Correspondence: Oddur Ingimarsson, odduri@landspitali.is
Key words: First episode psychosis, schizophrenia spectrum
disorders, early intervention psychosis, employment,
vocational predictors, cannabis.
Functional recovery after first episode psychosis rehabilitation in an early intervention psychosis center in Iceland
BACKGROUND: Because of the early onset and disabling symptoms of schizophrenia spectrum
disorders many individuals with these disorders are unemployed from an early age and disability
pension rates are high. The aim of this study was to assess functional recovery and identify
vocational predictors among young first episode psychosis patients registered in an early
intervention psychosis center in Iceland in 2010-2020.
METHODS: The study is a retrospective cohort study based on the medical records of those who
were discharged from Laugaras, the only early intervention psychosis program in Iceland after
six months or longer rehabilitation in 2010-2020 (n=144). Univariate and multivariate logistic
regression was used to identify vocational predictors.
RESULTS: 75% of patients were unemployed at admission to the early intervention center but
over half of the patients were employed or in school at discharge. Vocational rehabilitation was
the strongest vocational predictor (OR 13.93, 95% CI 3.85-63.89). Other vocational predictors
were those that reflect a disabling psychiatric disorder and social functioning before the onset of
early intervention. 66% of patients had a history of cannabis use which had a negative impact on
employment and education at discharge.
CONCLUSIONS: In spite of intensive rehabilitation at an early intervention center, almost half of the
patients were neither employed nor in school at discharge. The strongest vocational predictor was
vocational rehabilitation which was also one of few vocational predictors that can be influenced by
admission to an early intervention psychosis center. It therefore seems important to ensure that
effective vocational rehabilitation is readily available at early intervention psychosis centers.
doi 10.17992/lbl.2022.06.695